About Avego
Avego is a private equity firm founded in 2015. It is primarily based in Alpharetta, United States. In the last 12 months, it has participated in 7 funding rounds.
Overall Avego portfolio has seen 4 IPOs and 3 acquisitions, namely Immunocore, Escient Pharmaceuticals and MapLight. A lot of funds co-invest with Avego, with names like PFM Health Sciences sharing a substantial percentage of its portfolio.
Avego has a team of 19 people, including 7 partners.
Key Metrics
Avego's Portfolio
They have invested in a total of 23 companies. Their most recent investment was in Basis (Series A round) on Mar 02, 2026. Here is the most recent investment by Avego:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Mar 02, 2026 | Series A | 9447 | ||
Jan 27, 2026 | Series B | 2852 | ||
Jan 08, 2026 | Series B | 8426 | ||
Dec 22, 2025 | Series A | 3477 |
Here is the portfolio snapshot of Avego:
Investments by Year
The maximum number of investments were made in 2023
Team profile of Avego
Avego has a team of 19 members including 7 Partners and 2 Principals located in United States, Ireland and 1 more location. Avego's team does not sit on the board of any company as of now.Here is a list of top team members in Avego:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | New York City | - | ||
Partner | Marietta | - | - | |
Partner | Roswell | - | ||
Partner | Brooklyn | - | - | |
Partner | United States | - | ||
Partner | Alpharetta | - | ||
Partner | Alpharetta | - | ||
Principal | United States | - | - | |
Principal | New York | - | - | |
Advisor | Maryland | - | - | |
Associate | - | - |
Co-investors of Avego
Over the past 11 years, 61 investors have co-invested in Avego's portfolio companies.
- Top Co-investors of Avego: 61 investors entered a company along with Avego. These include investors like PFM Health Sciences (2 companies).
Avego News
•
Alveus Therapeutics Raises $37M in Series A Extension FundingFinSMEs•Mar 02, 2026•Basis, Jeito, Avego, Omega Funds and 5 others
•
TRex Bio Raises $50M to Advance Eczema Drug TestingBioPharmaDive•Jan 27, 2026•TRexBio, Affinity Asset Advisors, Avego, Johnson & Johnson Innovation and 8 others
•
Andera Partners Co-leads $160M Series A for Alveus to Advance Obesity TherapiesWebDisclosure•Jan 08, 2026•Andera Partners, Alveus Pharma, New Rhein, Avego and 4 others
•
Parabilis gets $305M to conquer 'undruggable' proteins after early successEndpoints•Jan 08, 2026•Parabilis Medicines, Johnson & Johnson, Frazier Life Sciences, Rock Springs Capital and 19 others
•
•
Amsterdam’s myTomorrows scores $29M to accelerate global access to experimental treatmentsTech Funding News•Nov 11, 2025•myTomorrows, Avego
•
•
CellCentric lands $120M to power clinical trials of oral cancer drug inobrodibTech Funding News•May 20, 2025•CellCentric, RA Capital Management, Forbion, Avego and 1 other
•
PBS Biotech boosts leadership, secures $17M to accelerate next-gen cell therapies.intelligence360•Jan 20, 2025•PBS Biotech, Avego, Broadoak Capital Partners
•
PBS Biotech Raises $17M in Growth FundingFinSMEs•Jan 06, 2025•PBS Biotech, Avego, Broadoak Capital Partners
